Evidence map›Paper›PMID 39266287›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2024

Development of

Rick Wray, Audrey Mauguen, Laure Michaud, Doris Leithner, Randy Yeh, Nadeem Riaz, Rosna Mirtcheva, Eric Sherman, Richard Wong, John Humm and 2 more

Abstract readValidation Study
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Frontiers in medicine · 2025
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rick WrayDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Audrey MauguenDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Laure MichaudDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Doris LeithnerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Randy YehDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Nadeem RiazDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Rosna MirtchevaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Eric ShermanDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Richard WongDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; and.
John HummDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
Nancy LeeDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Heiko SchöderDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; schoderh@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Tumor hypoxia, an integral biomarker to guide radiotherapy, can be imaged with

Indexed as

MisonidazolePositron Emission Tomography Computed TomographyAgedFemaleHumansImage Interpretation, Computer-AssistedMaleMiddle AgedObserver VariationOropharyngeal NeoplasmsReproducibility of ResultsTumor HypoxiafluoromisonidazoleMisonidazolefluoromisonidazoleFMISOinterpretation criteriaPET/CT

Identifiers

PMID39266287
PMCPMC11448606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.